Physician profile
Anne Pinou
NPI 1891890216
$1,007.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2021: $15.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $239.02 | 2019 | |
| Amarin Pharma, INC. | $119.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $89.69 | 2019 | |
| Glaxosmithkline, LLC. | $73.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.66 | 2019 | |
| Arbor Pharmaceuticals, INC. | $63.07 | 2019 | |
| Abbvie INC. | $48.34 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.53 | 2019 | |
| Daiichi Sankyo INC. | $41.38 | 2019 | |
| Merck Sharp & Dohme LLC | $41.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.02 | 2019 | |
| Scilex Pharmaceuticals INC. | $38.14 | 2019 | |
| Pfizer INC. | $34.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.30 | 2019 | |
| Shire North American Group INC | $19.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Pinou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.